2 Vaccine composition for dog canine parvovirus using canine parvovirus type 2 and there uses thereof
The present invention relates to a vaccine composition for mammalian parvovirus comprising canine parvovirus type 2 isolated in South Korea or a subculture thereof and a method for preventing parvovirus infection using the same. In addition, the present invention relates to a method for preparing a vaccine composition for mammalian parvovirus, which comprises a step of isolating parvovirus from a sample obtained from the nasal cavity of a mammal and attenuating or inactivating the same. The present invention provides a live or dead vaccine composition which is obtained by isolating canine parvovirus type 2b in South Korea, attenuating or inactivating the same, so as to prevent parvovirus infection more effectively than the CPV-2 vaccine strain currently used in South Korea while having low cytotoxicity. In addition, the present invention can be used as a vaccine for animals other than companion dogs which may be infected with CPV-2 or variants thereof..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Europäisches Patentamt - (2022) vom: 05. Apr. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
CHOI IN SOO [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2022-04-05, Last update posted on www.tib.eu: 2023-06-12, Last updated: 2023-06-16 |
|---|
| Patentnummer: |
KR20220043366 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA014119234 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA014119234 | ||
| 003 | DE-627 | ||
| 005 | 20230616042625.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230215s2022 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA014119234 | ||
| 035 | |a (EPA)KR20220043366 | ||
| 035 | |a (EPA)81182427 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a CHOI IN SOO |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 2 Vaccine composition for dog canine parvovirus using canine parvovirus type 2 and there uses thereof |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2022-04-05, Last update posted on www.tib.eu: 2023-06-12, Last updated: 2023-06-16 | ||
| 520 | |a The present invention relates to a vaccine composition for mammalian parvovirus comprising canine parvovirus type 2 isolated in South Korea or a subculture thereof and a method for preventing parvovirus infection using the same. In addition, the present invention relates to a method for preparing a vaccine composition for mammalian parvovirus, which comprises a step of isolating parvovirus from a sample obtained from the nasal cavity of a mammal and attenuating or inactivating the same. The present invention provides a live or dead vaccine composition which is obtained by isolating canine parvovirus type 2b in South Korea, attenuating or inactivating the same, so as to prevent parvovirus infection more effectively than the CPV-2 vaccine strain currently used in South Korea while having low cytotoxicity. In addition, the present invention can be used as a vaccine for animals other than companion dogs which may be infected with CPV-2 or variants thereof. | ||
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a bio | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a PARK BYUNG JOO |4 aut | |
| 700 | 0 | |a HAN SANG HOON |4 aut | |
| 700 | 0 | |a AHN HEE SEOP |4 aut | |
| 700 | 0 | |a KIM YONG HYUN |4 aut | |
| 700 | 0 | |a GO HYEON JEONG |4 aut | |
| 700 | 0 | |a LEE JOONG BOK |4 aut | |
| 700 | 0 | |a PARK SEUNG YONG |4 aut | |
| 700 | 0 | |a SONG CHANG SEON |4 aut | |
| 700 | 0 | |a LEE SANG WON |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2022) vom: 05. Apr. |
| 773 | 1 | 8 | |g year:2022 |g day:05 |g month:04 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/81182427/publication/KR20220043366A1?q=KR20220043366 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2022 |b 05 |c 04 |
| 951 | |a AR | ||
| 952 | |j 2022 |b 05 |c 04 | ||